John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
176
Chevron
CVX
$403B
| $44.6M | 0.13% |
528,324
-2,538,968
| -83% | -$206M |
|
177
Toronto Dominion Bank
TD
$194B
| $44.5M | 0.13% |
788,339
+669,127
| +561% | +$33.9M |
|
178
Equity Lifestyle Properties
ELS
$12.7B
| $44.5M | 0.13% |
701,764
+455,285
| +185% | +$28.1M |
|
179
Chewy
CHWY
$9.83B
| $44.4M | 0.13% |
+493,569
| New | +$36M |
|
180
Dolby
DLB
$6.11B
| $44.3M | 0.13% |
456,137
+228,752
| +101% | +$18.9M |
|
|
181
CALL
Amazon
AMZN
$2.79T
| $44M | 0.13% |
270,000
+170,000
| +170% | +$27.1M |
|
182
KKR & Co
KKR
$97.4B
| $43.9M | 0.13% |
1,083,925
+691,232
| +176% | +$26.1M |
|
183
PUT
Microsoft
MSFT
$3.59T
| $43.8M | 0.13% |
197,000
+62,400
| +46% | +$13.4M |
|
184
Sabre
SABR
$848M
| $43.7M | 0.13% |
3,639,183
-407,434
| -10% | -$3.77M |
|
185
Under Armour
UAA
$2.32B
| $43.7M | 0.13% |
2,546,843
-82,758
| -3% | -$1.26M |
|
186
Box
BOX
$4.56B
| $43.7M | 0.13% |
2,421,332
-413,208
| -15% | -$7.2M |
|
187
TripAdvisor
TRIP
$1.17B
| $43.3M | 0.12% |
1,503,961
+649,523
| +76% | +$15.6M |
|
188
CRISPR Therapeutics
CRSP
$5.75B
| $43.1M | 0.12% |
281,235
+42,724
| +18% | +$5.05M |
|
189
Kohl's
KSS
$2B
| $42.9M | 0.12% |
1,053,395
-2,283,318
| -68% | -$66.4M |
|
190
iShares Russell 2000 ETF
IWM
$81.9B
| $42.7M | 0.12% |
+217,892
| New | +$38.1M |
|
191
McCormick & Company Non-Voting
MKC
$14.9B
| $42.6M | 0.12% |
445,791
-23,401
| -5% | -$2.21M |
|
192
ON Semiconductor
ON
$28.9B
| $42.5M | 0.12% |
1,297,104
+710,086
| +121% | +$19.8M |
|
193
Lincoln National
LNC
$8.07B
| $42.4M | 0.12% |
842,219
-113,598
| -12% | -$4.83M |
|
194
Jack in the Box
JACK
$331M
| $42.1M | 0.12% |
453,492
+73,074
| +19% | +$6.39M |
|
195
Sherwin-Williams
SHW
$84.1B
| $42M | 0.12% |
171,537
+170,616
| +18,525% | +$40.5M |
|
|
MIK
196
DELISTED
Michaels Stores, Inc
MIK
| $41.9M | 0.12% |
3,218,689
+1,534,232
| +91% | +$15.6M |
|
|
AUY
197
DELISTED
Yamana Gold, Inc.
AUY
| $41.5M | 0.12% |
7,259,622
+5,724,849
| +373% | +$32.2M |
|
|
MRO
198
DELISTED
Marathon Oil Corporation
MRO
| $41M | 0.12% |
6,139,765
-410,299
| -6% | -$2.2M |
|
|
199
CALL
Microsoft
MSFT
$3.59T
| $40.7M | 0.12% |
183,000
+47,200
| +35% | +$10.1M |
|
200
Humana
HUM
$45.5B
| $40.5M | 0.12% |
98,754
-65,826
| -40% | -$27.4M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.